21 years of historical data (2005–2025) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
The Ensign Group, Inc. trades at 30.1x earnings, 12% above its 5-year average of 27.0x, sitting at the 95th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.2x, the stock trades at a premium of 36%. On a free-cash-flow basis, the stock trades at 27.7x P/FCF, roughly in line with the 5-year average of 28.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $10.3B | $10.3B | $7.7B | $6.4B | $5.4B | $4.8B | $4.1B | $2.5B | $2.0B | $1.1B | $1.1B |
| Enterprise Value | $13.9B | $13.9B | $9.2B | $7.8B | $6.6B | $5.8B | $4.9B | $3.8B | $2.2B | $1.4B | $1.3B |
| P/E Ratio → | 30.13 | 29.83 | 25.95 | 30.74 | 23.95 | 24.55 | 23.83 | 23.03 | 21.34 | 26.96 | 21.64 |
| P/S Ratio | 2.03 | 2.03 | 1.82 | 1.72 | 1.78 | 1.82 | 1.69 | 1.25 | 1.12 | 0.69 | 0.65 |
| P/B Ratio | 4.64 | 4.59 | 4.20 | 4.30 | 4.31 | 4.68 | 4.97 | 3.87 | 3.28 | 2.19 | 2.35 |
| P/FCF | 27.72 | 27.66 | 40.95 | 23.78 | 29.09 | 23.19 | 12.59 | 21.05 | 12.70 | 69.47 | 132.23 |
| P/OCF | 18.21 | 18.18 | 22.29 | 17.08 | 19.74 | 17.34 | 10.90 | 13.21 | 9.38 | 15.03 | 14.65 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
The Ensign Group, Inc.'s enterprise value stands at 25.9x EBITDA, 21% above its 5-year average of 21.5x. The Healthcare sector median is 14.0x, placing the stock at a 85% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.75 | 2.17 | 2.09 | 2.19 | 2.20 | 2.06 | 1.88 | 1.25 | 0.86 | 0.79 |
| EV / EBITDA | 25.88 | 25.84 | 20.90 | 23.78 | 18.48 | 18.27 | 17.81 | 21.24 | 16.84 | 15.60 | 10.03 |
| EV / EBIT | 32.11 | 32.06 | 23.45 | 27.75 | 22.27 | 21.83 | 21.79 | 29.03 | 25.14 | 30.52 | 14.08 |
| EV / FCF | — | 37.51 | 48.94 | 28.81 | 35.89 | 28.05 | 15.31 | 31.72 | 14.07 | 86.62 | 159.81 |
Margins and return-on-capital ratios measuring operating efficiency
The Ensign Group, Inc. earns an operating margin of 8.6%. Operating margins have expanded from 6.8% to 8.6% over the past 3 years, signaling improving operational efficiency. ROE of 16.9% indicates solid capital efficiency. ROIC of 7.0% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.7% | 13.7% | 15.7% | 15.8% | 17.1% | 17.8% | 17.0% | 14.3% | 12.5% | 10.8% | 11.4% |
| Operating Margin | 8.6% | 8.6% | 8.4% | 6.8% | 9.8% | 9.9% | 9.3% | 6.3% | 4.8% | 2.7% | 5.6% |
| Net Profit Margin | 6.8% | 6.8% | 7.0% | 5.6% | 7.4% | 7.4% | 7.1% | 5.4% | 5.3% | 2.5% | 3.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.9% | 16.9% | 17.9% | 15.3% | 19.8% | 21.2% | 23.1% | 17.6% | 16.8% | 8.4% | 11.3% |
| ROA | 6.8% | 6.8% | 6.7% | 5.5% | 7.1% | 7.2% | 6.9% | 6.2% | 8.1% | 3.8% | 5.7% |
| ROIC | 7.0% | 7.0% | 8.7% | 7.1% | 9.8% | 10.5% | 9.2% | 7.0% | 8.0% | 4.4% | 11.8% |
| ROCE | 10.2% | 10.2% | 9.7% | 8.1% | 11.4% | 12.1% | 11.2% | 8.8% | 9.5% | 5.2% | 13.5% |
Solvency and debt-coverage ratios — lower is generally safer
The Ensign Group, Inc. carries a Debt/EBITDA ratio of 7.7x, which is highly leveraged (147% above the sector average of 3.1x). Net debt stands at $3.7B ($4.2B total debt minus $504M cash). Interest coverage of 54.3x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.86 | 1.86 | 1.07 | 1.25 | 1.26 | 1.24 | 1.36 | 2.05 | 0.40 | 0.63 | 0.62 |
| Debt / EBITDA | 7.72 | 7.72 | 4.46 | 5.71 | 4.38 | 4.00 | 4.01 | 7.47 | 1.87 | 3.57 | 2.17 |
| Net Debt / Equity | — | 1.63 | 0.82 | 0.91 | 1.01 | 0.98 | 1.07 | 1.96 | 0.35 | 0.54 | 0.49 |
| Net Debt / EBITDA | 6.78 | 6.78 | 3.41 | 4.15 | 3.50 | 3.17 | 3.16 | 7.14 | 1.63 | 3.09 | 1.73 |
| Debt / FCF | — | 9.85 | 7.99 | 5.03 | 6.80 | 4.87 | 2.72 | 10.67 | 1.37 | 17.14 | 27.59 |
| Interest Coverage | 54.31 | 54.31 | 47.60 | 34.73 | 33.37 | 38.67 | 24.24 | 8.42 | 5.73 | 3.29 | 13.03 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.42x means The Ensign Group, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | 1.42 | 1.56 | 1.42 | 1.34 | 1.22 | 1.04 | 1.20 | 1.29 | 1.63 | 1.58 |
| Quick Ratio | 1.42 | 1.42 | 1.56 | 1.42 | 1.34 | 1.22 | 1.04 | 1.20 | 1.29 | 1.63 | 1.58 |
| Cash Ratio | 0.64 | 0.64 | 0.71 | 0.72 | 0.57 | 0.53 | 0.44 | 0.22 | 0.15 | 0.25 | 0.33 |
| Asset Turnover | — | 0.93 | 0.91 | 0.89 | 0.88 | 0.92 | 0.94 | 0.86 | 1.48 | 1.45 | 1.65 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 45.97 | 48.82 | 47.47 | 49.27 | 45.67 | 46.34 | 55.38 | 52.40 | 60.53 | 53.91 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
The Ensign Group, Inc. returns 0.3% to shareholders annually — split between a 0.1% dividend yield and 0.2% buyback yield. The payout ratio of 4.2% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 3.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.4% | 0.5% | 0.8% | 0.8% |
| Payout Ratio | 4.2% | 4.2% | 4.6% | 6.2% | 5.4% | 5.9% | 6.4% | 9.2% | 10.2% | 21.5% | 16.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.3% | 3.4% | 3.9% | 3.3% | 4.2% | 4.1% | 4.2% | 4.3% | 4.7% | 3.7% | 4.6% |
| FCF Yield | 3.6% | 3.6% | 2.4% | 4.2% | 3.4% | 4.3% | 7.9% | 4.8% | 7.9% | 1.4% | 0.8% |
| Buyback Yield | 0.2% | 0.2% | 0.0% | 0.0% | 0.6% | 0.2% | 0.6% | 0.3% | 0.1% | 0.7% | 2.8% |
| Total Shareholder Yield | 0.3% | 0.3% | 0.2% | 0.2% | 0.8% | 0.5% | 0.9% | 0.7% | 0.6% | 1.5% | 3.5% |
| Shares Outstanding | — | $59M | $58M | $57M | $57M | $57M | $56M | $56M | $54M | $53M | $52M |
Compare ENSG with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $10B | 30.1 | 25.9 | 27.7 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 | |
| $3B | 21.8 | 15.5 | 17.4 | 37.3% | 8.7% | 11.7% | 8.4% | 0.5 | |
| $1B | 37.5 | 25.4 | 22.7 | — | 5.5% | 8.6% | 5.7% | 7.5 | |
| $2B | 18.9 | 12.7 | 17.7 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 | |
| $344M | -3.6 | 17.9 | 7.1 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 | |
| $2B | 13.9 | 12.0 | 5.3 | 11.5% | 6.1% | 7.3% | 4.8% | 7.8 | |
| $2B | -2.1 | 8.4 | — | 17.6% | 11.7% | -41.4% | 5.9% | 4.6 | |
| $10B | 7.2 | 6.0 | 12.2 | 90.4% | 11.5% | 21.0% | 12.3% | 2.1 | |
| $2B | -23.4 | 10.0 | 9.4 | 23.1% | 11.8% | -2.2% | 4.1% | 7.1 | |
| $697M | -151.7 | 8.4 | 10.6 | 46.9% | 6.0% | -0.8% | 5.7% | 0.9 | |
| $2B | 983.3 | 23.7 | 22.8 | 42.5% | 0.4% | 0.2% | 0.3% | 2.4 | |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 21 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs National HealthCare Corporation.
Start ComparisonQuick answers to the most common questions about buying ENSG stock.
The Ensign Group, Inc.'s current P/E ratio is 30.1x. The historical average is 18.9x. This places it at the 95th percentile of its historical range.
The Ensign Group, Inc.'s current EV/EBITDA is 25.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.5x.
The Ensign Group, Inc.'s return on equity (ROE) is 16.9%. The historical average is 20.3%.
Based on historical data, The Ensign Group, Inc. is trading at a P/E of 30.1x. This is at the 95th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Ensign Group, Inc.'s current dividend yield is 0.14% with a payout ratio of 4.2%.
The Ensign Group, Inc. has 13.7% gross margin and 8.6% operating margin.
The Ensign Group, Inc.'s Debt/EBITDA ratio is 7.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.